Staging of classic Kaposi's sarcoma: A useful tool for therapeutic choices

Lucia Brambilla, Vinicio Boneschi, Michela Taglioni, Silvia Ferrucci

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Three hundred patients with classic Kaposi's sarcoma (CKS) have attended our Department of Dermatology over a period of 20 years. Many of them have been treated by systemic chemotherapy with good responses. Due to the highly variable clinical evolution of the disease, it was, however, often difficult for us to decide whether or not to treat elderly patients. We therefore attempted to establish a new staging system based on objective criteria that more closely follow the clinical variability of CKS and make the therapeutic choices easier. The proposed staging system comprises 4 stages, each further divided according to the speed of disease evolution and presence of complications that can severely impair the quality of life. The application of this staging system to our patients has shown that evolution is prevalently slow in the maculo-nodular and infiltrative stages I and II and faster during the florid and disseminated stages III and IV. Complications are mainly present in the rapidly evolving florid and disseminated stages, with visceral involvement in the more aggressive forms. Based on these findings, we are employing systemic therapy in the florid and disseminated stages and in the infiltrative stage only in case of rapidly evolving or slowly evolving but complicated disease.

Original languageEnglish
Pages (from-to)83-86
Number of pages4
JournalEuropean Journal of Dermatology
Volume13
Issue number1
Publication statusPublished - Jan 2003

Fingerprint

Kaposi's Sarcoma
Dermatology
Therapeutics
Quality of Life
Drug Therapy

Keywords

  • Classic Kaposi's sarcoma
  • Staging
  • Therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Staging of classic Kaposi's sarcoma : A useful tool for therapeutic choices. / Brambilla, Lucia; Boneschi, Vinicio; Taglioni, Michela; Ferrucci, Silvia.

In: European Journal of Dermatology, Vol. 13, No. 1, 01.2003, p. 83-86.

Research output: Contribution to journalArticle

@article{729c248106864a0b9279813abcac95ee,
title = "Staging of classic Kaposi's sarcoma: A useful tool for therapeutic choices",
abstract = "Three hundred patients with classic Kaposi's sarcoma (CKS) have attended our Department of Dermatology over a period of 20 years. Many of them have been treated by systemic chemotherapy with good responses. Due to the highly variable clinical evolution of the disease, it was, however, often difficult for us to decide whether or not to treat elderly patients. We therefore attempted to establish a new staging system based on objective criteria that more closely follow the clinical variability of CKS and make the therapeutic choices easier. The proposed staging system comprises 4 stages, each further divided according to the speed of disease evolution and presence of complications that can severely impair the quality of life. The application of this staging system to our patients has shown that evolution is prevalently slow in the maculo-nodular and infiltrative stages I and II and faster during the florid and disseminated stages III and IV. Complications are mainly present in the rapidly evolving florid and disseminated stages, with visceral involvement in the more aggressive forms. Based on these findings, we are employing systemic therapy in the florid and disseminated stages and in the infiltrative stage only in case of rapidly evolving or slowly evolving but complicated disease.",
keywords = "Classic Kaposi's sarcoma, Staging, Therapy",
author = "Lucia Brambilla and Vinicio Boneschi and Michela Taglioni and Silvia Ferrucci",
year = "2003",
month = "1",
language = "English",
volume = "13",
pages = "83--86",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Staging of classic Kaposi's sarcoma

T2 - A useful tool for therapeutic choices

AU - Brambilla, Lucia

AU - Boneschi, Vinicio

AU - Taglioni, Michela

AU - Ferrucci, Silvia

PY - 2003/1

Y1 - 2003/1

N2 - Three hundred patients with classic Kaposi's sarcoma (CKS) have attended our Department of Dermatology over a period of 20 years. Many of them have been treated by systemic chemotherapy with good responses. Due to the highly variable clinical evolution of the disease, it was, however, often difficult for us to decide whether or not to treat elderly patients. We therefore attempted to establish a new staging system based on objective criteria that more closely follow the clinical variability of CKS and make the therapeutic choices easier. The proposed staging system comprises 4 stages, each further divided according to the speed of disease evolution and presence of complications that can severely impair the quality of life. The application of this staging system to our patients has shown that evolution is prevalently slow in the maculo-nodular and infiltrative stages I and II and faster during the florid and disseminated stages III and IV. Complications are mainly present in the rapidly evolving florid and disseminated stages, with visceral involvement in the more aggressive forms. Based on these findings, we are employing systemic therapy in the florid and disseminated stages and in the infiltrative stage only in case of rapidly evolving or slowly evolving but complicated disease.

AB - Three hundred patients with classic Kaposi's sarcoma (CKS) have attended our Department of Dermatology over a period of 20 years. Many of them have been treated by systemic chemotherapy with good responses. Due to the highly variable clinical evolution of the disease, it was, however, often difficult for us to decide whether or not to treat elderly patients. We therefore attempted to establish a new staging system based on objective criteria that more closely follow the clinical variability of CKS and make the therapeutic choices easier. The proposed staging system comprises 4 stages, each further divided according to the speed of disease evolution and presence of complications that can severely impair the quality of life. The application of this staging system to our patients has shown that evolution is prevalently slow in the maculo-nodular and infiltrative stages I and II and faster during the florid and disseminated stages III and IV. Complications are mainly present in the rapidly evolving florid and disseminated stages, with visceral involvement in the more aggressive forms. Based on these findings, we are employing systemic therapy in the florid and disseminated stages and in the infiltrative stage only in case of rapidly evolving or slowly evolving but complicated disease.

KW - Classic Kaposi's sarcoma

KW - Staging

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0037283434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037283434&partnerID=8YFLogxK

M3 - Article

C2 - 12609790

AN - SCOPUS:0037283434

VL - 13

SP - 83

EP - 86

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 1

ER -